PLAT and myocardial infarction: In the context of treating thrombotic occlusion associated with MI, tPA-FSNs dual loaded with a small molecule Rho-kinase inhibitor, Y-27632, were found to localize to injured heart tissue and significantly improve left ventricular ejection fraction 2 and 4 weeks post-MI [76].